BY SRH
Texas has recorded an increase of 15,000 measles vaccinations this year compared to 2024. However, this has coincided with a significant measles outbreak that has exceeded the total number of cases reported throughout the entire United States last year.
The measles vaccine virus is a result of gain-of-function research and has the potential to shed onto unvaccinated individuals.
In a publication from May 2016 in The Journal of Infectious Diseases, U.S. military biodefense experts assert that the live virus present in the measles (MMR) vaccine is developed through a method that might be classified, according to contemporary definitions, as GOF research.
Gain-of-function experiments have the potential to enhance the infectiousness of viruses.
The wild-type measles virus (Montefiore 89 strain) is believed to primarily utilize a receptor known as CD150 for entry into and infection of immune cells.
The vaccine strain, known as the Edmonston strain, undergoes laboratory manipulation to enhance its capacity to bind to an additional receptor, CD46. This receptor is more prevalent in the body and is expressed on the majority of human nucleated cells.
The measles virus introduced into individuals vaccinated with the MMR has the capacity to infiltrate a greater number of cells relative to the wild-type virus, owing to its developed capability to utilize an extra cellular receptor.
The vaccine virus is also capable of shedding.
A study published in August 2024 in the peer-reviewed Journal of Clinical Virology indicates that the measles vaccine virus can be shed by recently vaccinated children for a duration of 29 days. This suggests that vaccinated individuals have the potential to transmit the virus to unvaccinated individuals for approximately one month.
A study conducted by the CDC in 1995 indicated that 83% of vaccinated children exhibited the presence of measles virus in their urine.
The presence of a genetically modified vaccine virus that can shed for nearly a month and infect a wider array of human cells than the wild-type strain raises a critical inquiry: Is the vaccine contributing to the observed surge?
